EP Life Sciences Ltd. — Form D/A

EP Life Sciences Ltd. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-03-21. $46.3M was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
Michael S FierroDirectorNew York, NY
Kabir S KapoorDirectorNEW YORK, NY
Gregory S LinkDirectorGrand Cayman, E9
Marty S PiccinichDirectorNEW YORK, NY
Ralph S WoodfordDirectorGrand Cayman, E9
Ralph WoodfordRelated PersonGrand Cayman, E9
Gregory LinkRelated PersonGeorge Town, Grand Cayman, E9
Patrick JC ShawDirectorNew York, NY
Marty PiccinichRelated PersonNew York, NY
Michael FierroRelated PersonNew York, NY
Kabir S KapoorRelated PersonNEW YORK, NY
Gregory W LinkDirectorGrand Cayman, E9
Ralph W WoodfordDirectorGrand Cayman, E9
Kurt JC DudasDirectorNew York, NY
Steven W DavdsonDirectorNEW YORK, NY
Kurt S DudasDirectorNEW YORK, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2026-03-16D/A$52.8M
2024-03-26D/A$46.1M
2023-03-27D/A$46.9M
2022-03-28D/A$48.5M
2021-06-08D/A$44.6M
2020-06-08D/A$31.3M
2019-06-17D/A$29.1M
2018-06-28D

More